ACE Report Cover
Hyaluronic acid versus placebo injection on POD1 following ACL reconstruction
Language
Download
Cite
+ Favorites
Language
Download
Cite
+ Favorites
AceReport Image
SPORTS MEDICINE
Hyaluronic acid versus placebo injection on POD1 following ACL reconstruction .

Early Viscosupplementation After Anterior Cruciate Ligament Reconstruction: A Randomized Controlled Trial

Am J Sports Med. 2016 Oct;44(10):2572-2578

60 patients scheduled for arthroscopic ACL reconstruction were randomized to receive an injection of either hyaluronic acid or placebo on the first day following the procedure. The purpose of this study was to compare measures of pain, function, and health-related quality of life between groups over a 12-month follow-up to determine if the use of hyaluronic acid can provide benefits in this patient population. The results demonstrated no significant differences between groups in clinical or functional scores. When comparing the active range of motion and leg girth between the operative limb and the contralateral limb, significantly smaller differences were observed in the HA group compared to the placebo at 1 and 2 months, respectively.

Unlock the Full ACE Report

You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now

Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics

Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics

Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions

Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics

Or upgrade today and gain access to all OrthoEvidence
content for as little as $1.99 per week.
0 of 4 monthly FREE articles unlocked
You've reached your limit of 4 free articles views this month

Access to OrthoEvidence for as little as $1.99 per week.

Stay connected with latest evidence. Cancel at any time.
  • Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
  • Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
  • Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Upgrade
Welcome Back!
Forgot Password?
Start your FREE trial today!

Account will be affiliated with


OR
Forgot Password?

OR
Please check your email

If an account exists with the provided email address, a password reset email will be sent to you. If you don't see an email, please check your spam or junk folder.

For further assistance, contact our support team.

Translate ACE Report

OrthoEvidence utilizes a third-party translation service to make content accessible in multiple languages. Please note that while every effort is made to ensure accuracy, translations may not always be perfect.

Cite this ACE Report

OrthoEvidence. Hyaluronic acid versus placebo injection on POD1 following ACL reconstruction. ACE Report. 2017;6(2):19. Available from: https://myorthoevidence.com/AceReport/Show/hyaluronic-acid-versus-placebo-injection-on-pod1-following-acl-reconstruction

Copy Citation
Please login to enable this feature

To access this feature, you must be logged into an active OrthoEvidence account. Please log in or create a FREE trial account.

Premium Member Feature

To access this feature, you must be logged into a premium OrthoEvidence account.

Share this ACE Report